articles
- A cornucopia of Shigella phages from the Cornhusker State. 538:45-52. 2019
- Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category. 519:99-105. 2018
- Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen display. 516:102-107. 2018
- Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture. 517:148-156. 2017
- Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. 501:35-46. 2017
- Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction. 500:161-168. 2017
- Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction. 505:193-209. 2017
- Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505. 510:22-28. 2017
- Immunological and pathological consequences of coxsackievirus RNA persistence in the heart. 512:104-112. 2017
- Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein. 512:161-171. 2017
- Resistance of human plasmacytoid dendritic CAL-1 cells to infection with lymphocytic choriomeningitis virus (LCMV) is caused by restricted virus cell entry, which is overcome by contact of CAL-1 cells with LCMV-infected cells. 511:106-113. 2017
- Binding and entry of a non-enveloped T=4 insect RNA virus is triggered by alkaline pH. 498:277-287. 2016
- Capture and characterization of influenza A virus from primary samples using glycan bead arrays. 493:128-135. 2016
- TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo. 498:69-81. 2016
- Adenovirus membrane penetration: Tickling the tail of a sleeping dragon. 479:591-599. 2015
- Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes. 475:37-45. 2015
- Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein. 468:10-18. 2014
- The delta domain of the HK97 major capsid protein is essential for assembly. 456:171-178. 2014
- The genome, proteome and phylogenetic analysis of Sinorhizobium meliloti phage ΦM12, the founder of a new group of T4-superfamily phages. 450:84-97. 2014
- The structure of Sinorhizobium meliloti phage ΦM12, which has a novel T=19l triangulation number and is the founder of a new group of T4-superfamily phages. 450:205-212. 2014
- Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes. 458:22-32. 2014
- Differential segregation of nodaviral coat protein and RNA into progeny virions during mixed infection with FHV and NoV. 454:280-290. 2014
- Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. 454:139-144. 2014
- Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6. 458:190-208. 2014
- Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy. 452:152-157. 2014
- Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals. 439:81-88. 2013
- Dual-color HIV reporters trace a population of latently infected cells and enable their purification. 446:283-292. 2013
- Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid. 441:162-170. 2013
- Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants. 446:56-65. 2013
- Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. 435:92-101. 2013
- Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores. 436:162-172. 2013
- Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus. 442:114-121. 2013
- Snapshots: Chromatin control of viral infection. 435:141-156. 2013
- The role of proteolytic processing and the stable signal peptide in expression of the old world arenavirus envelope glycoprotein ectodomain. 436:127-133. 2013
- Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells. 434:2-4. 2012
- CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection.. 429:163-170. 2012
- Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus a. 427:118-126. 2012
- Disulfide-bond formation by a single cysteine mutation in adenovirus protein vi impairs capsid release and membrane lysis. 428:41-47. 2012
- Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor pf-429242. 423:14-22. 2012
- In vitro evolution of h5n1 avian influenza virus toward human-type receptor specificity. 422:105-113. 2012
- Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo. 429:74-90. 2012
- Treatment of mice with human monoclonal antibody 24 h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection. 414:146-152. 2011
- Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies. 411:416-425. 2011
- Decoding arenavirus pathogenesis: Essential roles for alpha-dystroglycan-virus interactions and the immune response. 411:170-179. 2011
- Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza h5n1 viruses. 413:139-147. 2011
- Extraneural manifestations of prion infection in gpi-anchorless transgenic mice. 411:1-8. 2011
- Molecular characterization of drosophila cells persistently infected with flock house virus. 419:43-53. 2011
- Receptor specificity of subtype h1 influenza a viruses isolated from swine and humans in the united states. 412:401-410. 2011
- The ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. 419:72-83. 2011
- Antibody-mediated neutralization of ebola virus can occur by two distinct mechanisms. 401:228-235. 2010
- Crystallization and preliminary X-ray diffraction analysis of human adenovirus. 402:209-214. 2010
- Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection. 397:260-269. 2010
- Insights into adenovirus host cell interactions from structural studies. 384:380-388. 2009
- Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. 390:151-156. 2009
- Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design. 388:185-190. 2009
- TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif. 378:371-376. 2008
- A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. 382:107-114. 2008
- An aptamer that neutralizes r5 strains of hiv-1 binds to core residues of gp120 in the ccr5 binding site. 381:46-54. 2008
- Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis b surface antigen particles. 373:72-84. 2008
- Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. 377:170-183. 2008
- Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. 375:573-579. 2008
- Feline immunodeficiency virus orfa alters gene expression of splicing factors and proteasome-ubiquitination proteins. 371:394-404. 2008
- Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity. 375:637-645. 2008
- Neutralizing activity of antibodies to the v3 loop region of hiv-1 gp120 relative to their epitope fine specificity. 381:251-260. 2008
- Relationship of hiv-1 and siv envelope glycoprotein trimer occupation and neutralization. 377:364-378. 2008
- A comparative immunogenicity study of hiv-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. 366:245-262. 2007
- Analysis of the neutralization breadth of the anti-v3 antibody f425-b4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. 364:441-453. 2007
- Changes in the V3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta 32 heterozygote. 362:163-178. 2007
- Chronic wasting disease of deer and elk in transgenic mice: Oral transmission and pathobiology. 365:136-143. 2007
- Deletions within the 5 ' utr of coxsackievirus b3: Consequences for virus translation and replication. 360:120-128. 2007
- Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse . 361:93-102. 2007
- Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. 363:156-165. 2007
- Mapping and restriction of a dominant viral CD4(+) T cell core epitope by both MHC class I and MHC class II. 363:113-123. 2007
- Measles virus-dendritic cell interaction via slam inhibits innate immunity: Selective signaling through tlr4 but not other tlrs mediates suppression of il-12 synthesis. 358:251-257. 2007
- Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. 360:264-274. 2007
- The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. 367:367-374. 2007
- Vesicular stomatitis virus glycoprotein g activates a specific antiviral toll-like receptor 4-dependent pathway. 362:304-313. 2007
- Cd4 t cell control primary measles virus infection of the cns: Regulation is dependent on combined activity with either cd8 t cells or with b cells: Cd4, cd8 or b cells alone are ineffective. 347:234-245. 2006
- Characterization of polymorphism displayed by the coat protein mutants of tomato bushy stunt virus. 349:222-229. 2006
- Phosphoinositide 3-kinase: From viral oncoprotein to drug target. 344:131-138. 2006
- Rescue of the prototypic arenavirus LCMV entirely from plasmid. 350:370-380. 2006
- The infectivity and host range of the ecotropic porcine endogenous retrovirus, perv-c, is modulated by residues in the c-terminal region of its surface envelope protein. 346:108-117. 2006
- Viral persistence: Parameters, mechanisms and future predictions. 344:111-118. 2006
- An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor. 338:133-143. 2005
- Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins. 331:33-46. 2005
- Characterization of antibody responses to purified hiv-1 gp120 glycoproteins fused with the molecular adjuvant c3d. 340:277-284. 2005
- Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. 333:293-300. 2005
- Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding lassa virus nucleoprotein. 335:87-98. 2005
- Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion. 341:215-230. 2005
- In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity. 332:1-7. 2005
- Maturation of a tetravirus capsid alters the dynamic properties and creates a metastable complex. 334:17-27. 2005
- Selective recognition of oligomeric hiv-1 primary isolate envelope glycoprotelins by potently neutralizing ligands requires efficient precursor cleavage. 332:145-156. 2005
- Systemic trafficking of plant virus nanoparticles in mice via the oral route. 343:224-235. 2005
- Does toll-like receptor 3 play a biological role in virus infections?. 322:231-238. 2004
- Effect of polyanion-resistance on HIV-1 infection. 325:389-398. 2004
- Electron microscopy of an alpha-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus. 325:207-215. 2004
- Factors limiting the immunogenicity of hiv-1 gp120 envelope glycoproteins. 330:233-248. 2004
- Generation and analysis of an rna vaccine that protects against coxsackievirus b3 challenge. 330:196-208. 2004
- Measles virus interacts with human slam receptor on dendritic cells to cause immuno suppression. 323:292-302. 2004
- Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. 329:454-464. 2004
- N-linked glycosylation in the CXCR4 N-tenninus inhibits binding to HIV-1 envelope glycoproteins. 324:140-150. 2004
- The refined structure of nudaurelia capensis omega virus reveals control elements for a t=4 capsid maturation. 318:192-203. 2004
- Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. 325:432-445. 2004
- Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan. 316:213-220. 2003
- Analysis of rna packaging in wild-type and mosaic protein capsids of flock house virus using recombinant baculovirus vectors. 305:10-24. 2003
- Effects of the cowpea chlorotic mottle bromovirus beta-hexamer structure on virion assembly. 306:280-288. 2003
- Evidence for assembly-dependent folding of protein and rna in an icosahedral virus. 314:26-33. 2003
- Human rhinovirus capsid dynamics is controlled by canyon flexibility. 314:34-44. 2003
- Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). 308:37-47. 2003
- Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. 314:168-178. 2003
- Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. 315:159-173. 2003
- Structure-based, targeted deglycosylation of hiv-1 gp120 and effects on neutralization sensitivity and antibody recognition. 313:387-400. 2003
- Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay. 300:236-243. 2002
- Inducible system in human hepatoma cell lines for hepatitis C virus production. 303:79-99. 2002
- One, two, or three step: Measles virus receptor dance. 299:162-163. 2002
- Stability of rice yellow mottle virus and cellular compartmentalization during the infection process in oryza sativa (l). 297:98-108. 2002
- A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. 279:78-89. 2001
- Antibody neutralization epitopes and integrin binding sites on nonenveloped viruses. 288:189-191. 2001
- Antibody neutralization of the extracellular enveloped form of vaccinia virus. 280:132-142. 2001
- Characterization of virus-like particles assembled in a recombinant baculovirus system expressing the capsid protein of a fish nodavirus. 290:50-58. 2001
- Disruption of differentiated functions during viral infection in vivo - v. Mapping of a locus involved in susceptibility of mice to growth hormone deficiency due to persistent lymphocytic choriomeningitis virus infection. 281:61-66. 2001
- Evidence that the hypermutated m protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive cns disease. 291:215-225. 2001
- Specific packaging of nodaviral rna2 requires the n-terminus of the capsid protein. 285:165-175. 2001
- Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele. 270:98-110. 2000
- Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice. 272:438-449. 2000
- Antibody and virus: Binding and neutralization. 270:1-3. 2000
- Cell receptors involved in adenovirus entry. 274:1-4. 2000
- Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology. 271:276-288. 2000
- Cytokine-mediated control of viral infections. 273:221-227. 2000
- Defining parameters for successful immunocytotherapy of persistent viral infection. 266:257-263. 2000
- Enhancing DNA immunization. 268:233-238. 2000
- Human xenograft models for virus infection. 271:215-219. 2000
- Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. 274:391-401. 2000
- Synergistic interactions of antibodies in rate of virus neutralization. 270:386-396. 2000
- Transgenic mice expressing human hla and cd8 molecules generate hla-restricted measles virus cytotoxic t lymphocytes of the same specificity as humans with natural measles virus infection. 275:286-293. 2000
- V and c proteins of measles virus function as virulence factors in vivo. 267:80-89. 2000
- Vaccination to treat persistent viral infection. 268:411-419. 2000
- Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele. 253:193-207. 1999
- Augmentation of human influenza a virus-specific cytotoxic t lymphocyte memory by influenza vaccine and adjuvanted carriers (iscoms). 259:256-261. 1999
- Carboxy-terminal five amino acids of the nucleocapsid protein of vesicular stomatitis virus are required for encapsidation and replication of genome rna. 259:219-227. 1999
- High-yield reassortant influenza vaccine production virus has a mutation at an hla-a 2.1-restricted cd8(+) ctl epitope on the ns1 protein. 259:135-140. 1999
- Lymphotoxin-beta-deficient mice show defective antiviral immunity. 260:136-147. 1999
- Plasmid DNA vaccines are effective in the absence of ifn gamma. 263:175-183. 1999
- Rice tungro bacilliform virus open reading frame 3 encodes a single 37-kda coat protein. 253:319-326. 1999
- Structural and functional studies of the measles virus hemagglutinin: Identification of a novel site required for cd46 interaction. 256:142-151. 1999
- The refined crystal structure of cowpea mosaic virus at 2.8 Å resolution. 265:20-34. 1999
- Use of a high-affinity peptide that aborts mhc-restricted cytotoxic t lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. 256:246-257. 1999
- Comparison of the native ccmv virion with in vitro assembled ccmw virions by cryoelectron microscopy and image reconstruction. 244:212-218. 1998
- Crystallization and preliminary x-ray analysis of the dsdna bacteriophage hk97 mature empty capsid. 243:113-118. 1998
- Effects of mutations in the c-terminal region of nia protease on cis-cleavage between nia and nib. 241:94-100. 1998
- Identification of d-b- and k-b-restricted subdominant cytotoxic t-cell responses in lymphocytic choriomeningitis virus-infected mice. 240:158-167. 1998
- Interactions among hiv gp120, cd4, and cxcr4: Dependence on cd4 expression level, gp120 viral origin, conservation of the gp120 cooh- and nh(2)-termini and v1/v2 and v3 loops, and sensitivity to neutralizing antibodies. 248:394-405. 1998
- Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (fab 19) define a unique epitope on the fusion (f) glycoprotein. 252:373-375. 1998
- The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry. 244:530-541. 1998
- The df-1 chicken fibroblast cell line: Transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. 248:295-304. 1998
- How viruses escape from cytotoxic t lymphocytes: Molecular parameters and players. 234:179-185. 1997
- Low-affinity cytotoxic t-lymphocytes require ifn-gamma to clear an acute viral infection. 229:349-359. 1997
- Measles virus recognizes its receptor, cd46, via two distinct binding domains within scr1-2. 233:174-184. 1997
- Revelations of a captive: Retroviral qin and the oncogenicity of winged helix proteins. 238:1-7. 1997
- The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. 238:22-29. 1997
- The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic t cell epitope that is restricted by both h-2d(b) and h-2k(b) molecules. 234:62-73. 1997
- The structure of cucumber mosaic virus: Cryoelectron microscopy, x-ray crystallography, and sequence analysis. 232:91-97. 1997
- Viral persistent infection affects both transcriptional and posttranscriptional regulation of neuron-specific molecule GAP43. 230:147-154. 1997
- A neural substrate of hyperactivity in borna disease: Changes in brain dopamine receptors. 222:332-338. 1996
- Comparative properties of feline immunodeficiency virus (fiv) and human immunodeficiency virus type 1 (hiv-1) proteinases prepared by total chemical synthesis. 224:268-275. 1996
- Detection of borna disease virus antigen and rna in human autopsy brain samples from neuropsychiatric patients. 223:272-282. 1996
- Effects of internal cleavages and mutations in the C-terminal region of NIa protease of turnip mosaic potyvirus on the catalytic activity. 226:183-190. 1996
- Influence of orf2 on host cell tropism of feline immunodeficiency virus. 215:10-16. 1996
- Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against hsv. 215:101-106. 1996
- Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. 223:113-119. 1996
- Topically applied human recombinant monoclonal igg(1) antibody and its fab and f(ab')(2) fragments protect mice from vaginal transmission of hsv-2. 225:213-215. 1996
- Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. 220:508-515. 1996
- A quail long-term cell-culture transformed by a chimeric jun oncogene. 207:321-326. 1995
- An essential role for type-1 interferon-gamma in terminating persistent viral-infection. 212:244-250. 1995
- Assembly of the t=4 nudaurelia capensis omega virus capsid protein, posttranslational cleavage, and specific encapsidation of its messenger-rna in a baculovirus expression system. 207:89-97. 1995
- CTL escape viral variants. II. Biologic activity in vivo. 211:443-450. 1995
- Ctl escape viral variants .1. Generation and molecular characterization. 210:29-40. 1995
- Feline immunodeficiency virus (fiv)-specific cytotoxic t-lymphocytes from chronically infected cats are induced in-vitro by retroviral vector-transduced feline t-cells expressing the fiv capsid protein. 209:390-399. 1995
- Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines. 209:643-648. 1995
- The remarkable coding strategy of borna-disease virus - a new member of the nonsegmented negative strand rna viruses. 210:1-8. 1995
- A chromatographic analysis of capsid protein isolated from alfalfa mosaic-virus - zinc-binding and proteolysis cause distinct charge heterogeneity. 204:843-846. 1994
- Antigen presentation and cytotoxic t-lymphocyte killing studied in individual, living cells. 201:330-340. 1994
- Development of cowpea mosaic-virus as a high-yielding system for the presentation of foreign peptides. 202:949-955. 1994
- Direct imaging of interactions between an icosahedral virus and conjugate f-ab fragments by cryoelectron microscopy and x-ray crystallography. 204:777-788. 1994
- Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. 205:546-553. 1994
- Mechanism of lymphocytic choriomeningitis virus entry into cells. 198:1-9. 1994
- Receptor specificity in human, avian, and equine h2 and h3 influenza-virus isolates. 205:17-23. 1994
- Crystallization and preliminary-x-ray characterization of tobacco streak virus and a proteolytically modified form of the capsid protein. 196:328-331. 1993
- Cytotoxic T-lymphocytes cleanse viral gene-products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. 197:463-467. 1993
- Expression of an animal virus antigenic site on the surface of a plant-virus particle. 197:366-374. 1993
- Molecular-cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (fiv). 196:451-457. 1993
- Preliminary-x-ray data-analysis of crystalline cowpea chlorotic mottle virus. 193:234-241. 1993
- Virus-induced immunosuppression .1. Age at infection relates to a selective or generalized defect. 195:397-405. 1993
- Comoviruses and enteroviruses share a t-cell epitope. 186:238-246. 1992
- Measles-virus inhibits mitogen-induced t-cell proliferation but does not directly perturb the t-cell activation process inside the cell. 187:280-289. 1992
- Regulation of gene-expression directed by the long terminal repeat of the feline immunodeficiency virus. 187:165-177. 1992
- Sequence and analysis of the capsid protein of nudaurelia-capensis omega-virus, an insect virus with t=4 icosahedral symmetry. 190:806-814. 1992
- Wounding acts as a tumor promoter in chickens inoculated with avian-sarcoma virus-17. 188:373-377. 1992
- Avian cells expressing the murine Mx1 protein are resistant to influenza virus infection. 180:754-762. 1991
- The n2 neuraminidase of human influenza-virus has acquired a substrate-specificity complementary to the hemagglutinin receptor specificity. 180:10-15. 1991
- Molecular characterization of the Borna disease agent. 179:853-856. 1990
- Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. 178:393-400. 1990
- A zinc-finger-type binding domain in tobacco streak virus coat protein. 168:48-56. 1989
- Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions - block in expression of growth-hormone gene is at the level of transcriptional initiation. 168:232-235. 1989
- Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Epstein-Barr virus-transformed B lymphocytes. 168:31-39. 1989
- The primary structure of the lymphocytic choriomeningitis virus l-gene encodes a putative rna-polymerase. 169:377-384. 1989
- Analyses of the cyto-toxic lymphocyte-t responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. 162:321-327. 1988
- Hiv and hcmv coinfect brain-cells in patients with aids. 165:286-290. 1988
- The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein-kinase activity. 164:114-120. 1988
- Virus lymphocyte interactions .3. Biologic parameters of a virus variant that fails to generate ctl and establishes persistent infection in immunocompetent hosts. 164:507-516. 1988
- Virus lymphocyte interactions .4. Molecular characterization of lcmv armstrong (ctl+) small genomic segment and that of its variant, clone-13 (ctl-). 164:517-522. 1988
- Molecular characterization of the genomic-s rna segment from lymphocytic choriomeningitis virus. 157:145-155. 1987
- Perturbation of differentiated functions in vivo during persistent viral infection. III. Decreased growth hormone mRNA. 156:214-220. 1987
- Recognition of mono-valent sialosides by influenza-virus h-3 hemagglutinin. 160:502-506. 1987
- Nucleotide sequence of the CMII v-myc allele. 154:219-223. 1986
- Antibodies against small nuclear ribonucleoproteins immunoprecipitate complexes containing ts110 Moloney murine sarcoma virus genomic and messenger RNAs. 152:87-99. 1986
- Cytoskeletal organization, vinculin-phosphorylation, and fibronectin expression in transformed fibroblasts with different cell morphologies. 151:50-65. 1986
- Moloney murine sarcoma-virus encoded p37mos expressed in yeast has protein-kinase activity. 152:502-506. 1986
- Molecular and biological properties of MH2D12, a spontaneous mil deletion mutant of avian oncovirus MH2. 142:248-262. 1985
- Nucleotide sequence analysis of the chicken gene c-mil, the progenitor of the retroviral oncogene v-mil. 143:359-367. 1985
- An endogenous virus from lophortyx quail is the prototype for envelope subgroup-i of avian retroviruses. 143:595-602. 1985
- Avian retrovirus s13 - properties of the genome and of the transformation-specific protein. 145:154-164. 1985
- Cloned DNA of defective avian-sarcoma virus mutant la46 encodes the cis-acting temperature-sensitive defect in replication. 143:684-689. 1985
- Establishment of cell-lines persistently infected with foot-and-mouth-disease virus. 145:24-35. 1985
- H-1, c-13, and p-31 nuclear magnetic-resonance studies of cowpea mosaic-virus - detection and exchange of polyamines and dynamics of the rna. 141:43-50. 1985
- Influenza-virus hemagglutinins differentiate between receptor determinants bearing n-acetylneuraminic, n-glycollylneuraminic, and n,o-diacetylneuraminic acids. 144:279-282. 1985
- Isolation of 3 new avian-sarcoma viruses - asv-9, asv-17, and asv-25. 143:680-683. 1985
- Leukemogenicity of avian oncovirus-s13. 147:466-469. 1985
- Molecular-cloning of the prcii sarcoma viral genome and the chicken proto-oncogene c-fps. 143:300-308. 1985
- Perturbation of differentiated functions during viral infection in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency. 142:158-174. 1985
- Perturbation of differentiated functions during viral infection in vivo. II. Viral reassortants map growth hormone defect to the S RNA of the lymphocytic choriomeningitis virus genome. 142:175-182. 1985
- S13, a rapidly oncogenic replication-defective avian retrovirus. 145:141-153. 1985
- Immunological analysis of v-myc gene products using antibodies against a myc-specific synthetic peptide. 136:348-358. 1984
- Structural relationship between the chicken protooncogene c-mil and the retroviral oncogene v-mil. 137:217-224. 1984
- Antigenic analyses of influenza-virus hemagglutinins with different receptor-binding specificities. 138:174-177. 1984
- Black beetle virus - crystallization and particle symmetry. 133:119-127. 1984
- Early events in the infection of human lymphocyte-b by epstein-barr virus - the internalization process. 132:186-198. 1984
- Differential sensitivity of human, avian, and equine influenza-a viruses to a glycoprotein inhibitor of infection - selection of receptor specific variants. 131:394-408. 1983
- Mapping of the major histocompatibility complex and viral-antigens on the plasma-membrane of a measles virus-infected cell. 127:426-437. 1983
- Pathogenesis of the slow disease of the central nervous-system associated with wild mouse virus .3. Role of input virus and mcf recombinants in disease. 128:154-165. 1983
- Receptor determinants of human and animal influenza-virus isolates - differences in receptor specificity of the hemagglutinin-h-3 based on species of origin. 127:361-373. 1983
- Sialyloligosaccharide receptors of binding variants of polyoma-virus. 130:281-289. 1983
- The spherically averaged structures of cowpea mosaic-virus components by x-ray solution scattering. 127:65-73. 1983
- Ts transformation mutants of avian-sarcoma virus-prcii - lack of strict correlation between transforming ability and properties of the p105-associated kinase. 125:219-229. 1983
- A temperature-sensitive lesion affecting levels of transformation-specific viral RNA in a mutant of avian sarcoma virus PRCII. 116:646-649. 1982
- Class-ii defective avian-sarcoma viruses - comparative-analysis of genome structure. 120:453-464. 1982
- DNA and histone synthesis in butyrate-inhibited BSC-1 cells infected with SV40. 116:196-206. 1982
- Genome structure of the defective avian-sarcoma virus prciv. 117:156-164. 1982
- Structural similarities of proteins encoded by 3 classes of avian-sarcoma viruses. 121:274-287. 1982
- Structural-analysis of rauscher virus gp70 using monoclonal-antibodies - sites of antigenicity and p15(e) linkage. 123:187-205. 1982
- Avian-sarcoma virus prcii - conditional mutants temperature sensitive in the maintenance of fibroblast transformation. 109:193-197. 1981
- Characteristics of avian-sarcoma virus-strain prciv and comparison with strain prcii-p. 114:451-462. 1981
- Characterization of a 105,000 molecular-weight gag-related phosphoprotein from cells transformed by the defective avian-sarcoma virus prcii. 108:98-110. 1981
- Characterization of the transformation-specific sequences of avian erythroblastosis virus in normal vertebrate cells. 111:418-426. 1981
- Endogenous proviruses of random-bred chickens and ring-necked pheasants - analysis with restriction endonucleases. 108:222-229. 1981
- Esh avian-sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein-kinase activity. 111:386-400. 1981
- Integration of avian-sarcoma virus-DNA in chicken-cells. 108:208-221. 1981
- Monoclonal-antibodies to lymphocytic choriomeningitis and pichinde viruses - generation, characterization, and cross-reactivity with other arenaviruses. 113:73-85. 1981
- Polyoma-virus recognizes specific sialyloligosaccharide receptors on host-cells. 109:188-192. 1981
- The 28 S genomic RNA of avian sarcoma virus PRCII codes for the transformation-specific polyprotein P105. 112:757-761. 1981
- The pathogenicity and defectiveness of prcii - a new type of avian-sarcoma virus. 108:1-12. 1981
- The transformation-specific proteins of avian (fujinami and prc-ii) and feline (snyder-theilen and gardner-arnstein) sarcoma-viruses are immunologically related. 110:411-419. 1981
- Tyrosine-specific protein-kinase activity associated with p105 of avian-sarcoma virus prcii. 109:223-228. 1981
- Attenuation of avian reticuloendotheliosis virus - loss of the defective transforming component during serial passage of oncogenic virus in fibroblasts. 101:304-306. 1980
- Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. 100:475-483. 1980
- Crystalline cowpea mosaic-virus. 101:319-324. 1980
- Pathogenesis of the slow disease of the central nervous-system associated with wild mouse virus .2. Role of virus and host gene-products. 107:180-193. 1980
- Polyoma-virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. 103:505-509. 1980
- Recovered src genes are polymorphic and contain host markers. 105:71-85. 1980
- The genomic RNA of avian reticuloendotheliosis virus REV. 100:450-461. 1980
- Avian acute leukemia virus MC29: conserved and variable RNA sequences and recombination with helper virus. 99:121-134. 1979
- Avian erythroblastosis virus - transformation-specific sequences form a contiguous segment of 3.25-kb located in the middle of the 6-kb genome. 97:366-377. 1979
- Avian oncovirus mh2 is defective in gag, pol, and env. 92:278-284. 1979
- Avian oncovirus-mh2 - preferential growth in macrophages and exact size of the genome. 96:302-306. 1979
- Nonconditional replication-defective mutant of the schmidt-ruppin strain of rous-sarcoma virus. 92:285-290. 1979
- Protein-structure of lymphocytic choriomeningitis virus - evidence for a cell-associated precursor of the virion glycopeptides. 99:111-120. 1979
- Restitution of fibroblast-transforming ability in src deletion mutants of avian-sarcoma virus during animal passage. 93:413-426. 1979
- B-mux - unique murine c-type virus containing env gene of xenotropic viruses and gag gene of ecotropic virus. 90:255-264. 1978
- Biological, immunological, and biochemical evidence that hix virus is a recombinant between moloney leukemia-virus and a murine xenotropic c-type virus. 90:241-254. 1978
- Concordance of rna termini of recombinants from crosses between avian retroviruses with different termini. 85:367-377. 1978
- Defectiveness of mill hill 2, a carcinoma-inducing avian oncovirus. 89:162-178. 1978
- Genetic-analysis of defectiveness in strain mc29 avian-leukosis virus. 88:213-221. 1978
- Influence of carbohydrate on antigenicity of envelope glycoprotein of avian-myeloblastosis virus and b77 avian-sarcoma virus. 86:193-204. 1978
- Protein-structure of lymphocytic choriomeningitis virus - identification of virus structural and cell associated polypeptides. 89:133-145. 1978
- Structural-analysis of major envelope glycoprotein (gp70) of amphotropic and ecotropic type-c viruses of wild mice. 84:348-358. 1978
- Structure of southern bean mosaic-virus at 5 a resolution. 85:187-197. 1978
- Ts-pol mutants of avian-sarcoma viruses - mapping and demonstration of single cycle recombinants. 87:21-33. 1978
- Biological and biochemical studies on inactivation of avian onco-viruses by uv irradiation. 77:689-704. 1977
- Defectiveness of avian myelocytomatosis virus mc29 - isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide-synthesis. 82:431-448. 1977
- Endogenous leukosis viruses in avian family phasianidae. 76:740-750. 1977
- Glycolipids of chick-embryo fibroblasts infected with temperature-sensitive mutants of avian-sarcoma viruses. 76:485-493. 1977
- Phenotypic mixing between reticuloendotheliosis virus and avian-sarcoma viruses. 80:127-135. 1977
- Terminal oligonucleotides of avian tumor-virus rnas are genetically linked. 82:472-492. 1977
- Antibody-complement interactions with purified lymphocytic choriomeningitis virus. 73:59-71. 1976
- Avian-sarcoma virus mutant that is temperature sensitive for virion assembly. 69:35-49. 1976
- Inactivation and lysis of oncornaviruses by human-serum. 74:432-440. 1976
- Inhibition of avian-sarcoma virus-replication by glucosamine - specific effect on synthesis and processing of viral-proteins. 71:402-411. 1976
- Structure of southern bean mosaic-virus at 22.5-a resolution. 75:394-400. 1976
- Subgroup-specific antigenic determinants of avian RNA tumor virls structural proteins: analysis of virus recombinants. 73:372-380. 1976
- Temperature-sensitive mutants of avian-sarcoma viruses - genetic recombination with wild-type sarcoma-virus and physiological analysis of multiple mutants. 69:23-34. 1976
- Temperature-sensitive mutants of avian-sarcoma viruses - genetic-recombination between multiple or coordinate mutants and avian-leukosis viruses. 75:48-59. 1976
- RNA tumor virus specific sequences in nuclear DNA of several avian species. 65:524-534. 1975
- Susceptibility and resistance of chicken macrophages to avian RNA tumor viruses. 67:553-565. 1975
- Determination of defective function in 2 mutants of rous-sarcoma virus. 61:559-574. 1974
- Inhibition of avian-sarcoma virus replication by glucosamine. 58:449-456. 1974
- RNA tumor viruses of pheasants: characterization of avian leukosis subgroups F and G. 60:558-571. 1974
- Formation of syncytia in human lymphoblastoid cells infected with type c viruses. 55:453-463. 1973
- Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. 52:535-552. 1973
- Properties of an oncornavirus glycoprotein: Evidence for its presence on the surface of virions and infected cells. 55:464-475. 1973
- RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus. 54:207-219. 1973
- Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus. 50:65-75. 1972
- Lipid studies of Rous sarcoma virus and host cell membranes. 50:550-557. 1972
- An avian leukosis virus related to rsv(o): Properties and evidence for helper activity. 43:223-234. 1971
- Conditional lethal mutants of avian sarcoma viruses. I. Physiology of ts 75 and ts 149. 43:375-389. 1971
- Conditional lethal mutants of avian sarcoma viruses. Ii. Analysis of the temperature-sensitive lesion in ts 75. 46:745-753. 1971
- Genetically stable reassortment of markers during mixed infection with avian tumor viruses. 46:947-952. 1971
- Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. 46:920-938. 1971
- Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. 46:106-116. 1971
- Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses. 46:939-946. 1971
- Transformation by rous sarcoma virus: Effects on cellular glycolipids. 44:609-621. 1971
- Glycoprotein components of avian and murine RNA tumor viruses. 41:631-646. 1970
- The reproductive and cell-transforming capacities of avian sarcoma virus b77: Inactivation with uv light. 42:163-170. 1970
- Tissue injury in lymphocytic choriomeningitis viral infection: Virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. 42:805-813. 1970
- Characteristics of two new avian tumor virus subgroups. 39:18-30. 1969
- Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. 38:414-426. 1969
- Temperature sensitive mutants of an avian sarcoma virus. 39:930-931. 1969
- Effects of genetic cellular resistance on cell transformation and virus replication in chicken hematopoietic cell cultures infected with avian myeloblastosis virus (bai-a). 35:487-497. 1968
- Deae-dextran: Enhancement of cellular transformation induced by avian sarcoma viruses. 33:175-177. 1967
- Phenotypic mixing in the avian tumor virus group. 32:708-717. 1967
- Immunological relationships among envelope antigens of avian tumor viruses. 30:375-387. 1966
- Localization of avian tumor virus group-specific antigen in cell and virus. 29:377-384. 1966
- Patterns of viral interference in the avian leukosis and sarcoma complex. 30:368-374. 1966
- A heterogeneity of Rous sarcoma virus revealed by selectively resistant chick embryo cells. 25:237-247. 1965
- Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. 27:233-236. 1965
- Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens. 26:664-672. 1965
- Observations on the surface of cells infected with Rous sarcoma virus. 20:75-87. 1963
- Studies on the assay and multiplication of avian myeloblastosis virus. 19:92-104. 1963
- An avian leukosis virus associated with stocks of Rous sarcoma virus. 17:184-194. 1962
- Localization of infectious virus and viral antigen in chick fibroblasts during successive stages of infection with Rous sarcoma virus. 13:528-544. 1961